Today Nimbus and Celgene announced a significant partnership focused on autoimmune and inflammatory diseases. With that context, the author reviews the three unique elements of the Nimbus model
from Forbes Real Time https://www.forbes.com/sites/brucebooth/2017/10/03/nimbus-therapeutics-reaches-summit-for-deal-with-celgene/
via IFTTT
No comments:
Post a Comment